Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 BCL9L KMT2C NCOA6 SS18L1 MAML2 AIP ZMIZ1 MED1 KAT6B CREBBP	1.45e-09	303	60	11	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 BCL9L KMT2C NCOA6 SMYD1 SS18L1 MAML2 AIP ZMIZ1 MED1 KAT6B CREBBP	8.98e-08	562	60	12	GO:0003712
GeneOntologyMolecularFunction	chromatin binding	NCOA2 FOXO1 FOXO3 TRIM66 NCOA6 SATB2 MCMBP OGT MITF MED1 KAT6B NFAT5 CREBBP	2.28e-07	739	60	13	GO:0003682
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA2 BCL9L KMT2C NCOA6 UBQLN2 SMYD1 SS18L1 MAML2 AIP ZMIZ1 MED1 FEM1C KAT6B FEM1A CREBBP	1.19e-06	1160	60	15	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA2 BCL9L KMT2C NCOA6 UBQLN2 SGTB SMYD1 SS18L1 MAML2 AIP ZMIZ1 MED1 FEM1C KAT6B FEM1A CREBBP	1.61e-06	1356	60	16	GO:0060090
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM MGAM2	8.88e-06	2	60	2	GO:0004339
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA6 MED1 CREBBP	3.30e-05	21	60	3	GO:0042975
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 NCOA6 ZMIZ1 MED1	3.38e-05	61	60	4	GO:0030374
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM MGAM2	8.83e-05	5	60	2	GO:0004558
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA2 NCOA6 MED1	1.44e-04	34	60	3	GO:0046966
GeneOntologyMolecularFunction	chromatin DNA binding	FOXO1 FOXO3 OGT MED1 CREBBP	1.45e-04	167	60	5	GO:0031490
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM MGAM2	1.85e-04	7	60	2	GO:0090599
GeneOntologyMolecularFunction	aryl hydrocarbon receptor binding	NCOA2 AIP	3.15e-04	9	60	2	GO:0017162
GeneOntologyMolecularFunction	transcription factor binding	NCOA2 FOXO1 FOXO3 NCOA6 AIP MED1 NFAT5 FEM1A CREBBP	3.88e-04	753	60	9	GO:0008134
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2C SMYD1	3.93e-04	10	60	2	GO:0140999
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA6 MED1	5.43e-04	53	60	3	GO:0030331
GeneOntologyMolecularFunction	transcription coactivator binding	FOXO1 MED1 CREBBP	5.74e-04	54	60	3	GO:0001223
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA2 NCOA6 MED1	6.05e-04	55	60	3	GO:0042974
GeneOntologyMolecularFunction	polyubiquitin modification-dependent protein binding	UBQLN2 UBQLN1 UBQLN4	7.44e-04	59	60	3	GO:0031593
GeneOntologyMolecularFunction	transcription coregulator binding	FOXO1 FOXO3 MED1 CREBBP	8.33e-04	140	60	4	GO:0001221
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	KAT6B CREBBP	9.09e-04	15	60	2	GO:0010484
GeneOntologyMolecularFunction	glucosidase activity	MGAM MGAM2	9.09e-04	15	60	2	GO:0015926
GeneOntologyMolecularFunction	protein domain specific binding	NCOA2 NCOA6 OSBP ELMO3 OGT UBQLN1 AIP MED1 CREBBP	1.13e-03	875	60	9	GO:0019904
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	NCOA6 MED1	1.32e-03	18	60	2	GO:0042809
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NCOA2 NCOA6	1.63e-03	20	60	2	GO:0035259
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2C SMYD1	1.63e-03	20	60	2	GO:0042800
GeneOntologyMolecularFunction	N-acetyltransferase activity	OGT KAT6B CREBBP	1.67e-03	78	60	3	GO:0008080
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NCOA6	2.16e-03	23	60	2	GO:0046965
GeneOntologyMolecularFunction	modification-dependent protein binding	UBQLN2 UBQLN1 PSME4 UBQLN4	3.42e-03	206	60	4	GO:0140030
GeneOntologyMolecularFunction	poly(A) binding	RBMS1 PABPC4	3.42e-03	29	60	2	GO:0008143
GeneOntologyMolecularFunction	N-acyltransferase activity	OGT KAT6B CREBBP	3.59e-03	102	60	3	GO:0016410
GeneOntologyMolecularFunction	acetyltransferase activity	OGT KAT6B CREBBP	3.79e-03	104	60	3	GO:0016407
GeneOntologyMolecularFunction	single-stranded RNA binding	ILF3 RBMS1 PABPC4	4.54e-03	111	60	3	GO:0003727
GeneOntologyMolecularFunction	poly(U) RNA binding	RBMS1 PABPC4	4.68e-03	34	60	2	GO:0008266
GeneOntologyMolecularFunction	histone modifying activity	KMT2C SMYD1 KAT6B CREBBP	4.97e-03	229	60	4	GO:0140993
GeneOntologyMolecularFunction	poly-purine tract binding	RBMS1 PABPC4	5.53e-03	37	60	2	GO:0070717
GeneOntologyMolecularFunction	beta-catenin binding	FOXO1 FOXO3 BCL9L	5.65e-03	120	60	3	GO:0008013
GeneOntologyMolecularFunction	acyltransferase activity, transferring groups other than amino-acyl groups	ZDHHC15 OGT KAT6B CREBBP	5.69e-03	238	60	4	GO:0016747
GeneOntologyMolecularFunction	poly-pyrimidine tract binding	RBMS1 PABPC4	6.13e-03	39	60	2	GO:0008187
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	KMT2C SMYD1	7.75e-03	44	60	2	GO:0140938
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NCOA2 FOXO1 FOXO3 BCL9L KMT2C NCOA6 SATB2 OGT SS18L1 MITF MAML2 ZMIZ1 MED1 KAT6B NFAT5 CREBBP	1.46e-06	1390	60	16	GO:0045944
GeneOntologyCellularComponent	chromatin	NCOA2 FOXO1 FOXO3 TRIM66 BNC2 SATB2 OGT SS18L1 MITF ZMIZ1 MED1 KAT6B NFAT5 CREBBP	5.90e-05	1480	60	14	GO:0000785
GeneOntologyCellularComponent	nuclear protein-containing complex	NCOA2 FOXO3 BCL9L KMT2C NCOA6 SATB2 OGT SS18L1 UBQLN4 PRPF38B PLCG1 MED1 CREBBP	1.17e-04	1377	60	13	GO:0140513
GeneOntologyCellularComponent	transcription regulator complex	NCOA2 FOXO3 BCL9L NCOA6 SATB2 MED1 NFAT5 CREBBP	2.89e-04	596	60	8	GO:0005667
GeneOntologyCellularComponent	intracellular protein-containing complex	OGT UBQLN1 PSME4 UBQLN4 AIP MED1 FEM1C KAT6B FEM1A CREBBP	4.10e-04	972	60	10	GO:0140535
GeneOntologyCellularComponent	MLL3/4 complex	KMT2C NCOA6	5.25e-04	12	60	2	GO:0044666
GeneOntologyCellularComponent	proteasome complex	UBQLN1 PSME4 UBQLN4	9.45e-04	67	60	3	GO:0000502
MousePheno	abnormal parietal bone morphology	HSPG2 BNC2 SIK3 KAT6B DISP1	4.16e-06	64	53	5	MP:0000109
MousePheno	abnormal myocardium compact layer morphology	HSPG2 NCOA6 MED1 NFAT5 CREBBP	5.22e-06	67	53	5	MP:0004056
MousePheno	abnormal cranial suture morphology	HSPG2 BNC2 SIK3 KAT6B CREBBP	5.22e-06	67	53	5	MP:0002835
MousePheno	abnormal craniofacial suture morphology	HSPG2 BNC2 SIK3 KAT6B CREBBP	6.49e-06	70	53	5	MP:0030229
MousePheno	abnormal neurocranium morphology	HSPG2 BNC2 SATB2 SIK3 KAT6B CREBBP DISP1 PRRC2B	7.09e-06	269	53	8	MP:0000074
MousePheno	abnormal frontal bone morphology	HSPG2 BNC2 SATB2 CREBBP DISP1	1.04e-05	77	53	5	MP:0000107
MousePheno	abnormal fibrous joint morphology	HSPG2 BNC2 SATB2 SIK3 KAT6B CREBBP	1.15e-05	135	53	6	MP:0030878
MousePheno	embryonic lethality during organogenesis	FOXO1 BCL9L HSPG2 NCOA6 ATP2C1 SMYD1 RBMS1 PLCG1 AIP ZMIZ1 MED1 CREBBP DISP1	1.69e-05	876	53	13	MP:0006207
MousePheno	large fontanelles	BNC2 SIK3 CREBBP	2.78e-05	16	53	3	MP:0030388
MousePheno	abnormal occipital bone morphology	HSPG2 KAT6B CREBBP DISP1 PRRC2B	2.89e-05	95	53	5	MP:0005269
MousePheno	abnormal vascular development	FOXO1 HSPG2 NCOA6 PLCG1 AIP ZMIZ1 MED1 CREBBP DISP1 PRRC2B	3.06e-05	542	53	10	MP:0000259
MousePheno	increased prolactinoma incidence	FOXO3 AIP	4.22e-05	3	53	2	MP:0003505
MousePheno	increased pituitary adenohypophysis tumor incidence	FOXO3 AIP	8.42e-05	4	53	2	MP:0010350
MousePheno	abnormal fontanelle morphology	BNC2 SIK3 CREBBP	8.64e-05	23	53	3	MP:0000084
MousePheno	ventricle myocardium hypoplasia	NCOA6 SMYD1 MED1 CREBBP	1.48e-04	71	53	4	MP:0010502
MousePheno	abnormal craniofacial development	FOXO1 BNC2 NCOA6 SATB2 MITF ZMIZ1 DISP1 PRRC2B	1.82e-04	425	53	8	MP:0003935
MousePheno	abnormal myocardial trabeculae morphology	FOXO1 NCOA6 SMYD1 MED1 NFAT5	2.09e-04	144	53	5	MP:0002189
MousePheno	impaired placental function	NCOA6 MED1	2.10e-04	6	53	2	MP:0006372
MousePheno	abnormal vascular endothelial cell development	PLCG1 MED1 CREBBP	2.15e-04	31	53	3	MP:0003542
MousePheno	abnormal embryonic growth/weight/body size	FOXO1 BCL9L HSPG2 NCOA6 ZDHHC15 ATP2C1 RBM12 SMYD1 RBMS1 PLCG1 ZMIZ1 MED1 CREBBP DISP1	2.43e-04	1295	53	14	MP:0002088
MousePheno	abnormal vitelline vasculature morphology	FOXO1 NCOA6 AIP ZMIZ1 CREBBP PRRC2B	2.51e-04	235	53	6	MP:0003229
MousePheno	embryonic lethality during organogenesis, complete penetrance	FOXO1 BCL9L NCOA6 ATP2C1 SMYD1 PLCG1 ZMIZ1 MED1 CREBBP DISP1	2.56e-04	700	53	10	MP:0011098
MousePheno	abnormal visceral yolk sac morphology	FOXO1 BCL9L PLCG1 ZMIZ1 MED1 CREBBP	2.57e-04	236	53	6	MP:0001718
MousePheno	abnormal skeleton development	HSPG2 BNC2 SATB2 MITF SIK3 KAT6B CREBBP DISP1	2.57e-04	447	53	8	MP:0002113
MousePheno	abnormal prenatal growth/weight/body size	FOXO1 BCL9L HSPG2 NCOA6 ZDHHC15 ATP2C1 RBM12 SMYD1 RBMS1 MITF PLCG1 ZMIZ1 MED1 CREBBP DISP1	3.07e-04	1493	53	15	MP:0004196
MousePheno	myocardium hypoplasia	NCOA6 SMYD1 MED1 CREBBP	3.11e-04	86	53	4	MP:0010500
MousePheno	prenatal growth retardation	FOXO1 NCOA6 ZDHHC15 ATP2C1 RBM12 SMYD1 RBMS1 MITF PLCG1 MED1 CREBBP	3.44e-04	869	53	11	MP:0010865
MousePheno	absent organized vascular network	FOXO1 CREBBP	3.89e-04	8	53	2	MP:0000263
MousePheno	abnormal pharyngeal arch morphology	FOXO1 SATB2 ZMIZ1 DISP1 PRRC2B	4.61e-04	171	53	5	MP:0002884
MousePheno	abnormal angiogenesis	FOXO1 HSPG2 AIP ZMIZ1 MED1 CREBBP PRRC2B	4.80e-04	372	53	7	MP:0000260
MousePheno	microcephaly	BNC2 SATB2 OGT MED1	4.92e-04	97	53	4	MP:0000433
MousePheno	absent parietal bone	HSPG2 DISP1	4.99e-04	9	53	2	MP:0004419
MousePheno	abnormal extraembryonic tissue morphology	NCOA2 FOXO1 BCL9L NCOA6 OSBP PLCG1 AIP ZMIZ1 MED1 CREBBP PRRC2B	5.01e-04	908	53	11	MP:0002086
MousePheno	embryonic growth retardation	FOXO1 NCOA6 ZDHHC15 ATP2C1 RBM12 SMYD1 RBMS1 PLCG1 MED1 CREBBP	5.08e-04	763	53	10	MP:0003984
MousePheno	abnormal vein morphology	HSPG2 PSME4 AIP MED1 PRRC2B	5.26e-04	176	53	5	MP:0002725
MousePheno	ventricular hypoplasia	NCOA6 SMYD1 MED1 CREBBP	5.31e-04	99	53	4	MP:0000279
MousePheno	heart hypoplasia	NCOA6 SMYD1 MED1 CREBBP	6.17e-04	103	53	4	MP:0002740
MousePheno	short facial bone	HSPG2 SATB2 KAT6B CREBBP	6.40e-04	104	53	4	MP:0030384
MousePheno	thin myocardium compact layer	NCOA6 MED1 CREBBP	6.96e-04	46	53	3	MP:0004057
MousePheno	trabecula carnea hypoplasia	NCOA6 SMYD1 MED1	6.96e-04	46	53	3	MP:0000295
MousePheno	abnormal joint morphology	HSPG2 BNC2 SATB2 SIK3 KAT6B CREBBP PRRC2B	7.06e-04	397	53	7	MP:0002932
MousePheno	abnormal pharyngeal arch artery morphology	FOXO1 ZMIZ1 PRRC2B	7.42e-04	47	53	3	MP:0002672
MousePheno	decreased embryo size	BCL9L HSPG2 NCOA6 ATP2C1 RBMS1 ZMIZ1 MED1 CREBBP DISP1	7.49e-04	659	53	9	MP:0001698
MousePheno	abnormal cardiovascular development	FOXO1 HSPG2 NCOA6 PLCG1 AIP ZMIZ1 MED1 CREBBP DISP1 PRRC2B	7.50e-04	802	53	10	MP:0002925
MousePheno	abnormal first pharyngeal arch morphology	FOXO1 SATB2 DISP1	7.89e-04	48	53	3	MP:0006337
MousePheno	dilated liver sinusoidal space	HSPG2 MED1 PRRC2B	7.89e-04	48	53	3	MP:0000602
MousePheno	pale yolk sac	BCL9L ZMIZ1 MED1 CREBBP	7.90e-04	110	53	4	MP:0001722
MousePheno	abnormal axial skeleton morphology	HSPG2 BNC2 OSBP SATB2 OGT PABPC4 MITF KERA SIK3 R3HDM1 KAT6B CREBBP DISP1 PRRC2B	8.14e-04	1458	53	14	MP:0002114
MousePheno	pericardial effusion	FOXO1 HSPG2 NCOA6 MED1	8.17e-04	111	53	4	MP:0005312
MousePheno	abnormal cranium morphology	HSPG2 BNC2 SATB2 OGT MITF SIK3 KAT6B CREBBP DISP1 PRRC2B	8.33e-04	813	53	10	MP:0000438
MousePheno	embryonic lethality, incomplete penetrance	HSPG2 KMT2C NCOA6 RBMS1 AIP MED1 CREBBP	8.53e-04	410	53	7	MP:0011102
MousePheno	prenatal lethality prior to heart atrial septation, incomplete penetrance	HSPG2 KMT2C NCOA6 RBMS1 AIP MED1 CREBBP	8.53e-04	410	53	7	MP:0031660
MousePheno	perinatal lethality	CACNA1A HSPG2 BNC2 KMT2C NCOA6 SATB2 ILF3 TNRC6C SIK3 NFAT5 CREBBP DISP1	8.73e-04	1130	53	12	MP:0002081
MousePheno	abnormal long bone hypertrophic chondrocyte zone	HSPG2 MITF SIK3 KAT6B	8.74e-04	113	53	4	MP:0000165
MousePheno	abnormal myocardium layer morphology	FOXO1 HSPG2 NCOA6 SMYD1 MED1 NFAT5 CREBBP	9.03e-04	414	53	7	MP:0005329
MousePheno	abnormal craniofacial bone morphology	HSPG2 BNC2 SATB2 OGT MITF SIK3 KAT6B CREBBP DISP1 PRRC2B	9.50e-04	827	53	10	MP:0002116
MousePheno	abnormal ventricle myocardium morphology	NCOA6 SMYD1 MED1 CREBBP	9.64e-04	116	53	4	MP:0010499
MousePheno	abnormal heart layer morphology	FOXO1 HSPG2 NCOA6 SMYD1 MED1 NFAT5 CREBBP	1.01e-03	422	53	7	MP:0010545
MousePheno	abnormal vasculogenesis	FOXO1 PLCG1 CREBBP	1.11e-03	54	53	3	MP:0001622
MousePheno	abnormal tooth number	SATB2 CREBBP DISP1	1.24e-03	56	53	3	MP:0030611
MousePheno	increased pituitary adenoma incidence	FOXO3 AIP	1.25e-03	14	53	2	MP:0002041
MousePheno	delayed cranial suture closure	SIK3 KAT6B	1.25e-03	14	53	2	MP:0010743
MousePheno	abnormal palate morphology	HSPG2 BNC2 NCOA6 SATB2 CREBBP DISP1	1.30e-03	321	53	6	MP:0003755
MousePheno	facial bone hypoplasia	BNC2 SATB2 CREBBP	1.30e-03	57	53	3	MP:0030386
MousePheno	delayed bone ossification	HSPG2 SIK3 KAT6B CREBBP	1.35e-03	127	53	4	MP:0000060
MousePheno	myocardial trabeculae hypoplasia	NCOA6 SMYD1 MED1	1.37e-03	58	53	3	MP:0010503
MousePheno	increased pituitary gland tumor incidence	FOXO3 AIP	1.43e-03	15	53	2	MP:0010320
MousePheno	abnormal craniofacial morphology	FOXO1 HSPG2 BNC2 NCOA6 SATB2 OGT MITF ZMIZ1 SIK3 KAT6B CREBBP DISP1 PRRC2B	1.48e-03	1372	53	13	MP:0000428
MousePheno	craniofacial phenotype	FOXO1 HSPG2 BNC2 NCOA6 SATB2 OGT MITF ZMIZ1 SIK3 KAT6B CREBBP DISP1 PRRC2B	1.48e-03	1372	53	13	MP:0005382
MousePheno	abnormal pericardium morphology	FOXO1 HSPG2 NCOA6 MED1 DISP1	1.58e-03	225	53	5	MP:0000288
MousePheno	abnormal timing of postnatal eyelid opening	HSPG2 KMT2C MITF	1.59e-03	61	53	3	MP:0004874
MousePheno	abnormal cartilage morphology	HSPG2 SATB2 MITF SIK3 KAT6B DISP1	1.63e-03	336	53	6	MP:0000163
MousePheno	abnormal viscerocranium morphology	HSPG2 BNC2 SATB2 MITF SIK3 KAT6B CREBBP DISP1	1.64e-03	593	53	8	MP:0005274
MousePheno	abnormal liver lobule morphology	HSPG2 NCOA6 SIK3 MED1 PRRC2B	1.71e-03	229	53	5	MP:0008987
MousePheno	short mandible	HSPG2 SATB2 KAT6B	1.82e-03	64	53	3	MP:0000088
Domain	UBA	UBQLN2 UBQLN1 UBQLN4 TNRC6C SIK3	2.85e-07	44	60	5	IPR015940
Domain	UBA	UBQLN2 UBQLN1 UBQLN4 TNRC6C SIK3	3.99e-07	47	60	5	PS50030
Domain	Ubiquilin	UBQLN2 UBQLN1 UBQLN4	6.26e-07	6	60	3	IPR015496
Domain	UBA	UBQLN2 UBQLN1 UBQLN4 TNRC6C	2.48e-06	30	60	4	SM00165
Domain	STI1	UBQLN2 UBQLN1 UBQLN4	3.72e-06	10	60	3	SM00727
Domain	STI1_HS-bd	UBQLN2 UBQLN1 UBQLN4	3.72e-06	10	60	3	IPR006636
Domain	UBA	UBQLN2 UBQLN1 UBQLN4 TNRC6C	5.25e-06	36	60	4	PF00627
Domain	FOXO_KIX-bd	FOXO1 FOXO3	1.01e-05	2	60	2	IPR032068
Domain	Ubiquilin-1/2	UBQLN2 UBQLN1	1.01e-05	2	60	2	IPR028430
Domain	FOXO_KIX_bdg	FOXO1 FOXO3	1.01e-05	2	60	2	PF16675
Domain	6-PGluconate_DH_C-like	UBQLN2 UBQLN1 UBQLN4	2.94e-05	19	60	3	IPR008927
Domain	FOXO-TAD	FOXO1 FOXO3	3.04e-05	3	60	2	IPR032067
Domain	FOXO-TAD	FOXO1 FOXO3	3.04e-05	3	60	2	PF16676
Domain	UBA-like	UBQLN2 UBQLN1 UBQLN4 TNRC6C	5.29e-05	64	60	4	IPR009060
Domain	NtCtMGAM_N	MGAM MGAM2	6.06e-05	4	60	2	PF16863
Domain	Gal_mutarotase_N	MGAM MGAM2	6.06e-05	4	60	2	IPR031727
Domain	Nuc_rcpt_coact	NCOA2 CREBBP	1.51e-04	6	60	2	IPR009110
Domain	Glyco_hydro_31_AS	MGAM MGAM2	1.51e-04	6	60	2	IPR030458
Domain	TPR_REGION	OGT SGTB AIP FEM1C FEM1A	1.87e-04	165	60	5	PS50293
Domain	TPR	OGT SGTB AIP FEM1C FEM1A	1.87e-04	165	60	5	PS50005
Domain	Glyco_hydro_31	MGAM MGAM2	2.11e-04	7	60	2	IPR000322
Domain	TPR_11	OGT SGTB	2.11e-04	7	60	2	PF13414
Domain	Glyco_hydro_31	MGAM MGAM2	2.11e-04	7	60	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	MGAM MGAM2	2.11e-04	7	60	2	PS00129
Domain	UBIQUITIN_1	UBQLN2 UBQLN1 UBQLN4	2.27e-04	37	60	3	PS00299
Domain	Trefoil	MGAM MGAM2	2.81e-04	8	60	2	PF00088
Domain	UBQ	UBQLN2 UBQLN1 UBQLN4	3.55e-04	43	60	3	SM00213
Domain	P_TREFOIL_2	MGAM MGAM2	3.60e-04	9	60	2	PS51448
Domain	PD	MGAM MGAM2	3.60e-04	9	60	2	SM00018
Domain	ubiquitin	UBQLN2 UBQLN1 UBQLN4	4.62e-04	47	60	3	PF00240
Domain	-	OGT SGTB AIP FEM1C FEM1A	5.31e-04	207	60	5	1.25.40.10
Domain	RRM_1	RBM12 ENOX1 RBMS1 PABPC4 TNRC6C	5.42e-04	208	60	5	PF00076
Domain	-	MGAM MGAM2	5.48e-04	11	60	2	4.10.110.10
Domain	P_trefoil_dom	MGAM MGAM2	6.56e-04	12	60	2	IPR000519
Domain	RRM	RBM12 ENOX1 RBMS1 PABPC4 TNRC6C	6.57e-04	217	60	5	SM00360
Domain	UBIQUITIN_2	UBQLN2 UBQLN1 UBQLN4	6.96e-04	54	60	3	PS50053
Domain	RRM_dom	RBM12 ENOX1 RBMS1 PABPC4 TNRC6C	8.05e-04	227	60	5	IPR000504
Domain	RRM	RBM12 ENOX1 RBMS1 PABPC4 TNRC6C	8.54e-04	230	60	5	PS50102
Domain	Ubiquitin_dom	UBQLN2 UBQLN1 UBQLN4	8.58e-04	58	60	3	IPR000626
Domain	TPR-like_helical_dom	OGT SGTB AIP FEM1C FEM1A	9.05e-04	233	60	5	IPR011990
Domain	-	RBM12 ENOX1 RBMS1 PABPC4 TNRC6C	1.11e-03	244	60	5	3.30.70.330
Domain	Gal_mutarotase_SF_dom	MGAM MGAM2	1.34e-03	17	60	2	IPR011013
Domain	Nucleotide-bd_a/b_plait	RBM12 ENOX1 RBMS1 PABPC4 TNRC6C	1.42e-03	258	60	5	IPR012677
Domain	PHD	TRIM66 KMT2C KAT6B	1.81e-03	75	60	3	PF00628
Domain	Znf_PHD-finger	TRIM66 KMT2C KAT6B	2.10e-03	79	60	3	IPR019787
Domain	DHHC	KMT2C ZDHHC15	2.90e-03	25	60	2	PS50216
Domain	Znf_DHHC_palmitoyltrfase	KMT2C ZDHHC15	2.90e-03	25	60	2	IPR001594
Domain	PHD	TRIM66 KMT2C KAT6B	2.94e-03	89	60	3	SM00249
Domain	Znf_PHD	TRIM66 KMT2C KAT6B	3.13e-03	91	60	3	IPR001965
Domain	ZF_PHD_2	TRIM66 KMT2C KAT6B	3.54e-03	95	60	3	PS50016
Domain	ZF_PHD_1	TRIM66 KMT2C KAT6B	3.64e-03	96	60	3	PS01359
Domain	ARM-type_fold	ELMO3 UBQLN2 UBQLN1 PSME4 UTP20	4.62e-03	339	60	5	IPR016024
Domain	BROMODOMAIN_1	TRIM66 CREBBP	6.29e-03	37	60	2	PS00633
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 NCOA6 MED1 CREBBP	3.50e-07	18	48	4	M26942
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA2 NCOA6 MED1 CREBBP	1.96e-06	27	48	4	M26943
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	FOXO1 FOXO3 CREBBP	4.37e-06	10	48	3	M27945
Pathway	REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP	NCOA2 NCOA6 MED1 CREBBP	1.20e-05	42	48	4	M27172
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES	FOXO1 FOXO3 CREBBP	2.01e-05	16	48	3	M27940
Pathway	REACTOME_HEME_SIGNALING	NCOA2 NCOA6 MED1 CREBBP	2.24e-05	49	48	4	M41832
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA2 NCOA6 MED1 CREBBP	3.55e-05	55	48	4	M27145
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA2 NCOA6 MED1 CREBBP	3.55e-05	55	48	4	M27001
Pathway	REACTOME_CYTOPROTECTION_BY_HMOX1	NCOA2 NCOA6 MED1 CREBBP	5.02e-05	60	48	4	M41830
Pathway	PID_AR_PATHWAY	NCOA2 NCOA6 ZMIZ1 MED1	5.35e-05	61	48	4	M58
Pathway	PID_HDAC_CLASSIII_PATHWAY	FOXO1 FOXO3 CREBBP	9.12e-05	26	48	3	M32
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA2 NCOA6 MED1 CREBBP	9.20e-05	70	48	4	M938
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	NCOA2 FOXO1 NCOA6	1.56e-04	31	48	3	M39476
Pathway	REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION	FOXO1 FOXO3	1.69e-04	6	48	2	MM15660
Pathway	PID_SMAD2_3NUCLEAR_PATHWAY	NCOA2 FOXO1 FOXO3 CREBBP	1.70e-04	82	48	4	M2
Pathway	REACTOME_METABOLISM_OF_STEROIDS	NCOA2 NCOA6 OSBP MED1 CREBBP	1.71e-04	154	48	5	M27832
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA2 NCOA6 MED1 CREBBP	1.87e-04	84	48	4	M1008
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	NCOA2 FOXO1 FOXO3 KMT2C NCOA6 PSME4 SMYD1 SS18L1 MITF PLCG1 MAML2 TNRC6C MED1 CREBBP	2.03e-04	1432	48	14	M509
Pathway	BIOCARTA_PPARG_PATHWAY	MED1 CREBBP	2.36e-04	7	48	2	MM1573
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES	FOXO1 FOXO3	2.36e-04	7	48	2	MM15661
Pathway	WP_ANDROGEN_RECEPTOR_SIGNALING	NCOA2 FOXO1 ZMIZ1 CREBBP	2.54e-04	91	48	4	M39700
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	FOXO1 FOXO3 PSME4 TNRC6C	2.77e-04	93	48	4	M27572
Pathway	REACTOME_MITOCHONDRIAL_BIOGENESIS	NCOA2 NCOA6 MED1 CREBBP	3.12e-04	96	48	4	M26973
Pathway	BIOCARTA_PPARG_PATHWAY	MED1 CREBBP	3.14e-04	8	48	2	M22058
Pathway	WP_IL6_SIGNALING_PATHWAY	FOXO1 FOXO3 PLCG1 CREBBP	3.65e-04	100	48	4	MM15826
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	FOXO1 MAML2 CREBBP	3.87e-04	42	48	3	M17541
Pathway	REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES	KMT2C NCOA6 OGT	3.87e-04	42	48	3	M48018
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_	MGAM MGAM2	4.03e-04	9	48	2	M47622
Pathway	REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS	NCOA2 FOXO3 TNRC6C MED1 CREBBP ADH1A	4.76e-04	296	48	6	M27869
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	FOXO1 FOXO3	5.02e-04	10	48	2	M27095
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	FOXO1 FOXO3	5.02e-04	10	48	2	MM14778
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	NCOA2 OGT KAT6B	5.07e-04	46	48	3	MM14935
Pathway	REACTOME_ADIPOGENESIS	NCOA2 NCOA6 MED1 CREBBP	5.24e-04	110	48	4	M48259
Pathway	WP_ENERGY_METABOLISM	FOXO1 FOXO3 MED1	5.75e-04	48	48	3	M39590
Pathway	PID_PI3KCI_PATHWAY	FOXO3 PLCG1 ARF5	5.75e-04	48	48	3	M141
Pathway	PID_FOXO_PATHWAY	FOXO1 FOXO3 CREBBP	6.12e-04	49	48	3	M136
Pathway	WP_NAD_METABOLISM_SIRTUINS_AND_AGING	FOXO1 FOXO3	6.12e-04	11	48	2	M39439
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA6 MED1 CREBBP	6.83e-04	118	48	4	M27316
Pathway	REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS	NCOA2 NCOA6 PSME4 MED1 CREBBP	7.12e-04	210	48	5	M41836
Pathway	PID_KIT_PATHWAY	FOXO3 MITF CREBBP	7.28e-04	52	48	3	M231
Pathway	REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	FOXO1 FOXO3	7.33e-04	12	48	2	MM15657
Pathway	REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	FOXO1 FOXO3	7.33e-04	12	48	2	M27939
Pathway	PID_AR_TF_PATHWAY	NCOA2 FOXO1 CREBBP	7.70e-04	53	48	3	M151
Pathway	REACTOME_ESR_MEDIATED_SIGNALING	NCOA2 FOXO3 TNRC6C MED1 CREBBP	8.77e-04	220	48	5	M27794
Pathway	REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS	FOXO1 FOXO3 PSME4 PLCG1 MAML2 TNRC6C CREBBP	9.15e-04	464	48	7	M27547
Pathway	REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING	MAML2 CREBBP	1.01e-03	14	48	2	M27808
Pathway	WP_KIT_RECEPTOR_SIGNALING	FOXO3 MITF PLCG1	1.05e-03	59	48	3	M39350
Pathway	BIOCARTA_PITX2_PATHWAY	MED1 CREBBP	1.16e-03	15	48	2	MM1439
Pathway	WP_RUBINSTEINTAYBI_SYNDROME_1	FOXO1 CREBBP	1.16e-03	15	48	2	M48323
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	SS18L1 MITF TNRC6C CREBBP	1.19e-03	137	48	4	M48232
Pathway	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS	MAML2 CREBBP	1.32e-03	16	48	2	M27121
Pathway	BIOCARTA_PITX2_PATHWAY	MED1 CREBBP	1.32e-03	16	48	2	M8516
Pathway	REACTOME_HATS_ACETYLATE_HISTONES	NCOA2 OGT KAT6B CREBBP	1.36e-03	142	48	4	M27233
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	FOXO3 KMT2C CREBBP	1.40e-03	65	48	3	M39682
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	FOXO1 FOXO3 CREBBP	1.46e-03	66	48	3	M27938
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES	FOXO1 FOXO3	1.49e-03	17	48	2	M27946
Pathway	REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION	NCOA2 TNRC6C MED1 CREBBP	1.63e-03	149	48	4	M27888
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 MED1	1.68e-03	18	48	2	MM15034
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS	MITF TNRC6C	1.87e-03	19	48	2	M48238
Pathway	REACTOME_MAPK6_MAPK4_SIGNALING	FOXO1 FOXO3 PSME4	1.95e-03	73	48	3	MM15285
Pathway	REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP	2.07e-03	20	48	2	M27881
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOA2 KMT2C OGT KAT6B CREBBP	2.24e-03	272	48	5	M29619
Pathway	WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX	FOXO3 CREBBP	2.29e-03	21	48	2	M39593
Pathway	BIOCARTA_VDR_PATHWAY	MED1 CREBBP	2.51e-03	22	48	2	MM1370
Pathway	BIOCARTA_AKT_PATHWAY	FOXO1 FOXO3	2.51e-03	22	48	2	M15258
Pathway	REACTOME_FOXO_MEDIATED_TRANSCRIPTION	FOXO1 FOXO3	2.51e-03	22	48	2	MM15656
Pathway	WP_GLIOBLASTOMA_SIGNALING	FOXO1 FOXO3 PLCG1	2.81e-03	83	48	3	M39637
Pathway	WP_ANGIOGENESIS	PLCG1 CREBBP	2.99e-03	24	48	2	M39556
Pathway	BIOCARTA_VDR_PATHWAY	MED1 CREBBP	2.99e-03	24	48	2	M13404
Pathway	REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	MAML2 CREBBP	3.24e-03	25	48	2	M27880
Pathway	BIOCARTA_AKT_PATHWAY	FOXO1 FOXO3	3.50e-03	26	48	2	MM1345
Pathway	BIOCARTA_CARM_ER_PATHWAY	MED1 CREBBP	3.50e-03	26	48	2	M2499
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER	FOXO1 FOXO3	3.50e-03	26	48	2	M27558
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 BCL9L KMT2C NCOA6 SATB2 OGT SS18L1 MITF ZMIZ1 CREBBP PRRC2B	2.52e-11	351	61	11	38297188
Pubmed	Human transcription factor protein interaction networks.	NCOA2 BCL9L HSPG2 KMT2C NCOA6 SATB2 RBM12 OGT RBMS1 SS18L1 PABPC4 MITF TNRC6C ZMIZ1 R3HDM1 CREBBP PRRC2B	2.38e-10	1429	61	17	35140242
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 KMT2C NCOA6 SATB2 RBM12 ILF3 OGT UBQLN1 PABPC4 PRPF38B AIP MED1 CREBBP PRRC2B	5.38e-09	1103	61	14	34189442
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA2 KMT2C NCOA6 CREBBP	8.46e-09	14	61	4	12482968
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 RBM12 TNRC6C ZMIZ1 R3HDM1 CREBBP PRRC2B	9.49e-09	152	61	7	38360978
Pubmed	Herp enhances ER-associated protein degradation by recruiting ubiquilins.	UBQLN2 UBQLN1 UBQLN4	2.05e-08	4	61	3	18307982
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 BCL9L NCOA6 RBM12 OGT MED1 CREBBP PRRC2B	2.32e-08	268	61	8	33640491
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA2 NCOA6 MED1 CREBBP	4.06e-08	20	61	4	11877444
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NCOA6 MED1 CREBBP	5.01e-08	21	61	4	19596656
Pubmed	Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation.	NCOA6 MED1 CREBBP	5.12e-08	5	61	3	11912212
Pubmed	MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.	FOXO1 FOXO3 CREBBP	5.12e-08	5	61	3	12192052
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	FOXO3 KMT2C RAB3GAP1 ATP2C1 ILF3 OGT SLC25A39 RBMS1 KERA PRPF38B PLCG1 MAML2 MED1 R3HDM1	5.44e-08	1327	61	14	32694731
Pubmed	Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.	NCOA6 MED1 CREBBP	1.02e-07	6	61	3	15150259
Pubmed	RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control.	UBQLN2 UBQLN1 UBQLN4	1.02e-07	6	61	3	35247097
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 NCOA6 OSBP RAB3GAP1 SATB2 SS18L1 SIK3 MED1 CREBBP PRRC2B	1.56e-07	638	61	10	31182584
Pubmed	Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity between Shuttle Factors and Substrates at the Proteasome.	UBQLN2 UBQLN1 UBQLN4	1.79e-07	7	61	3	30664872
Pubmed	Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery.	UBQLN2 UBQLN1 UBQLN4	2.86e-07	8	61	3	23459205
Pubmed	D-cysteine is an endogenous regulator of neural progenitor cell dynamics in the mammalian brain.	FOXO1 FOXO3 SATB2	2.86e-07	8	61	3	34556581
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KMT2C NCOA6 SATB2 RBM12 PSME4 MAML2 SIK3 FEM1C KAT6B	3.50e-07	529	61	9	14621295
Pubmed	Oxidative stress-dependent regulation of Forkhead box O4 activity by nemo-like kinase.	FOXO1 FOXO3 CREBBP	4.28e-07	9	61	3	20874444
Pubmed	Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator.	NCOA6 MED1 CREBBP	1.12e-06	12	61	3	12189208
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 BCL9L KMT2C NCOA6 RBM12 ZMIZ1 CREBBP PRRC2B	1.34e-06	457	61	8	32344865
Pubmed	UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome.	UBQLN2 UBQLN1 UBQLN4	1.45e-06	13	61	3	27477512
Pubmed	Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.	NCOA2 MED1 CREBBP	1.45e-06	13	61	3	11266503
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	KMT2C NCOA6 RAB3GAP1 OGT	1.86e-06	50	61	4	37974198
Pubmed	Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne.	UBQLN2 UBQLN1 UBQLN4 TNRC6C	1.86e-06	50	61	4	31699778
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	KMT2C NCOA6 RBM12 TNRC6C SIK3 KAT6B	2.83e-06	225	61	6	12168954
Pubmed	GxE interactions between FOXO genotypes and drinking tea are significantly associated with prevention of cognitive decline in advanced age in China.	FOXO1 FOXO3	3.03e-06	2	61	2	24895270
Pubmed	CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.	FOXO3 NFAT5	3.03e-06	2	61	2	31504797
Pubmed	Association study to evaluate Foxo1 and Foxo3 gene polymorphisms in polycystic ovary syndrome: a preliminary case-control study and in silico analysis.	FOXO1 FOXO3	3.03e-06	2	61	2	36790598
Pubmed	FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.	FOXO1 FOXO3	3.03e-06	2	61	2	24448243
Pubmed	Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring.	FOXO1 FOXO3	3.03e-06	2	61	2	25010393
Pubmed	FoxO transcription factors support oxidative stress resistance in human chondrocytes.	FOXO1 FOXO3	3.03e-06	2	61	2	25186470
Pubmed	FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress.	FOXO1 FOXO3	3.03e-06	2	61	2	21159781
Pubmed	Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis.	FOXO1 FOXO3	3.03e-06	2	61	2	24269635
Pubmed	Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.	FOXO1 FOXO3	3.03e-06	2	61	2	16952979
Pubmed	Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization.	FOXO1 FOXO3	3.03e-06	2	61	2	16709600
Pubmed	FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.	FOXO1 FOXO3	3.03e-06	2	61	2	17254970
Pubmed	A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.	FOXO1 FOXO3	3.03e-06	2	61	2	22552808
Pubmed	Foxo in T Cells Regulates Thermogenic Program through Ccr4/Ccl22 Axis.	FOXO1 FOXO3	3.03e-06	2	61	2	31756626
Pubmed	Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors.	FOXO1 FOXO3	3.03e-06	2	61	2	15069012
Pubmed	Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling.	FOXO1 FOXO3	3.03e-06	2	61	2	27936162
Pubmed	Lower FOXO3 mRNA expression in granulosa cells is involved in unexplained infertility.	FOXO1 FOXO3	3.03e-06	2	61	2	28621049
Pubmed	Age-related reduction in the expression of FOXO transcription factors and correlations with intervertebral disc degeneration.	FOXO1 FOXO3	3.03e-06	2	61	2	28430387
Pubmed	Identification of human FEM1A, the ortholog of a C. elegans sex-differentiation gene.	FEM1C FEM1A	3.03e-06	2	61	2	11733146
Pubmed	Myoepithelioma-like Hyalinizing Epithelioid Tumors of the Hand With Novel OGT-FOXO3 Fusions.	FOXO3 OGT	3.03e-06	2	61	2	31567281
Pubmed	Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure.	FOXO1 FOXO3	3.03e-06	2	61	2	16979636
Pubmed	FOXO1 and FOXO3 Cooperatively Regulate Innate Lymphoid Cell Development.	FOXO1 FOXO3	3.03e-06	2	61	2	35757763
Pubmed	Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.	FOXO1 FOXO3	3.03e-06	2	61	2	16100571
Pubmed	A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities.	UBQLN2 UBQLN1	3.03e-06	2	61	2	29247619
Pubmed	Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells.	FOXO1 FOXO3	3.03e-06	2	61	2	22515357
Pubmed	[Analysis of FOXO1A and FOXO3A Gene Allele Association with Human Longevity].	FOXO1 FOXO3	3.03e-06	2	61	2	27529982
Pubmed	Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis.	UBQLN2 UBQLN1	3.03e-06	2	61	2	35063704
Pubmed	Kinetics of nuclear-cytoplasmic translocation of Foxo1 and Foxo3A in adult skeletal muscle fibers.	FOXO1 FOXO3	3.03e-06	2	61	2	22932683
Pubmed	Both FOXO3a and FOXO1 are involved in the HGF-protective pathway against apoptosis in endothelial cells.	FOXO1 FOXO3	3.03e-06	2	61	2	25952685
Pubmed	The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis.	FOXO1 FOXO3	3.03e-06	2	61	2	32332845
Pubmed	Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese.	FOXO1 FOXO3	3.03e-06	2	61	2	24489705
Pubmed	FOXOs in the impaired heart: New therapeutic targets for cardiac diseases.	FOXO1 FOXO3	3.03e-06	2	61	2	27890702
Pubmed	Effects of FOXO genotypes on longevity: a biodemographic analysis.	FOXO1 FOXO3	3.03e-06	2	61	2	20884733
Pubmed	Endothelial-specific FoxO1 depletion prevents obesity-related disorders by increasing vascular metabolism and growth.	FOXO1 FOXO3	3.03e-06	2	61	2	30511639
Pubmed	CBP/p300 as a co-factor for the Microphthalmia transcription factor.	MITF CREBBP	3.03e-06	2	61	2	9223672
Pubmed	Phospholipase C-gamma1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP.	PLCG1 NFAT5	3.03e-06	2	61	2	20080774
Pubmed	Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).	KAT6B CREBBP	3.03e-06	2	61	2	11157802
Pubmed	FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts.	FOXO1 FOXO3	3.03e-06	2	61	2	20142102
Pubmed	FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway.	FOXO1 FOXO3	3.03e-06	2	61	2	22931788
Pubmed	Foxo transcription factors control regulatory T cell development and function.	FOXO1 FOXO3	3.03e-06	2	61	2	21167754
Pubmed	Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations.	FOXO1 FOXO3	3.03e-06	2	61	2	19793722
Pubmed	P. gingivalis modulates keratinocytes through FOXO transcription factors.	FOXO1 FOXO3	3.03e-06	2	61	2	24265696
Pubmed	Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.	FOXO1 FOXO3	3.03e-06	2	61	2	18823877
Pubmed	Forkhead box class O transcription factors in liver function and disease.	FOXO1 FOXO3	3.03e-06	2	61	2	23855308
Pubmed	Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.	FOXO1 FOXO3	3.03e-06	2	61	2	21565617
Pubmed	Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology.	FOXO1 FOXO3	3.03e-06	2	61	2	19747349
Pubmed	Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver.	NCOA6 MED1	3.03e-06	2	61	2	16828057
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FOXO3 HSPG2 KMT2C NCOA6 PSME4 SLC25A39 KTI12 PLCG1 TNRC6C FEM1A PRRC2B	3.09e-06	1105	61	11	35748872
Pubmed	New nomenclature for chromatin-modifying enzymes.	NCOA2 KMT2C KAT6B CREBBP	3.15e-06	57	61	4	18022353
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA2 MED1 CREBBP	3.43e-06	17	61	3	19183483
Pubmed	Adipocyte arrestin domain-containing 3 protein (Arrdc3) regulates uncoupling protein 1 (Ucp1) expression in white adipose independently of canonical changes in β-adrenergic receptor signaling.	NCOA6 MED1 CREBBP	3.43e-06	17	61	3	28291835
Pubmed	Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene.	NCOA6 MED1 CREBBP	4.88e-06	19	61	3	22982455
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	MCMBP RBM12 OGT ZSCAN20 UBQLN1 ENOX1 SGTB RBMS1 SS18L1	5.62e-06	742	61	9	26871637
Pubmed	Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates.	UBQLN2 UBQLN1 PSME4 UBQLN4	5.69e-06	66	61	4	24811749
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	KMT2C NCOA6 OGT	5.73e-06	20	61	3	29785026
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	RBM12 ILF3 UBQLN1 PABPC4 UBQLN4 AIP MED1	6.35e-06	399	61	7	35987950
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 FOXO3 KMT2C ATP2C1 OGT PRPF38B PLCG1 TNRC6C ZMIZ1 KAT6B NFAT5 CREBBP	9.02e-06	1489	61	12	28611215
Pubmed	Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.	SS18L1 CREBBP	9.07e-06	3	61	2	14716005
Pubmed	A mutant allele encoding DNA binding-deficient FoxO1 differentially regulates hepatic glucose and lipid metabolism.	FOXO1 FOXO3	9.07e-06	3	61	2	25576059
Pubmed	FOXO transcription factors protect against the diet-induced fatty liver disease.	FOXO1 FOXO3	9.07e-06	3	61	2	28300161
Pubmed	Endothelial FoxO proteins impair insulin sensitivity and restrain muscle angiogenesis in response to a high-fat diet.	FOXO1 FOXO3	9.07e-06	3	61	2	27235148
Pubmed	Inhibition of FOXO1/3 promotes vascular calcification.	FOXO1 FOXO3	9.07e-06	3	61	2	25378413
Pubmed	Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock.	NCOA6 CREBBP	9.07e-06	3	61	2	14960326
Pubmed	STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O Forkhead transcription factors.	FOXO1 FOXO3	9.07e-06	3	61	2	21730069
Pubmed	FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.	FEM1C FEM1A	9.07e-06	3	61	2	18757445
Pubmed	FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.	FOXO1 FOXO3	9.07e-06	3	61	2	17254969
Pubmed	FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics.	FOXO1 FOXO3	9.07e-06	3	61	2	12857750
Pubmed	Coactivators for the orphan nuclear receptor RORalpha.	NCOA2 MED1	9.07e-06	3	61	2	10478845
Pubmed	Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.	FOXO3 MITF	9.07e-06	3	61	2	19188590
Pubmed	Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.	FOXO1 FOXO3	9.07e-06	3	61	2	16133873
Pubmed	Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues.	FOXO1 FOXO3	9.07e-06	3	61	2	10880363
Pubmed	CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer.	FOXO1 FOXO3	9.07e-06	3	61	2	30873749
Pubmed	SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells.	SATB2 CREBBP	9.07e-06	3	61	2	33124191
Pubmed	FoxO transcription factors 1 regulate mouse preimplantation embryo development.	FOXO1 FOXO3	9.07e-06	3	61	2	31396850
Interaction	SP7 interactions	NCOA2 BCL9L KMT2C NCOA6 SATB2 RBM12 SS18L1 MITF ZMIZ1 CREBBP PRRC2B	1.64e-09	304	61	11	int:SP7
Interaction	ERG interactions	NCOA2 KMT2C NCOA6 SATB2 ILF3 SS18L1 MITF CREBBP PRRC2B	2.23e-08	223	61	9	int:ERG
Interaction	ZG16 interactions	UBQLN2 UBQLN1 SGTB UBQLN4	3.69e-08	12	61	4	int:ZG16
Interaction	EGR2 interactions	NCOA2 BCL9L KMT2C NCOA6 SS18L1 MITF CREBBP PRRC2B	4.58e-08	171	61	8	int:EGR2
Interaction	EYA4 interactions	NCOA2 RBM12 OGT UBQLN2 TNRC6C ZMIZ1 R3HDM1 CREBBP PRRC2B	4.67e-08	243	61	9	int:EYA4
Interaction	HNF4A interactions	NCOA2 FOXO1 KMT2C NCOA6 SATB2 SS18L1 PABPC4 MED1 CREBBP	1.34e-07	275	61	9	int:HNF4A
Interaction	TFF1 interactions	UBQLN1 SGTB UBQLN4 MED1 CREBBP	1.48e-07	41	61	5	int:TFF1
Interaction	SERPINI2 interactions	UBQLN2 UBQLN1 SGTB UBQLN4	2.25e-07	18	61	4	int:SERPINI2
Interaction	SRGN interactions	UBQLN2 UBQLN1 SGTB UBQLN4	3.55e-07	20	61	4	int:SRGN
Interaction	UNK interactions	ZDHHC15 MCMBP OGT UBQLN1 RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B ARF5	3.72e-07	408	61	10	int:UNK
Interaction	CPEB4 interactions	TRIM66 UBQLN2 RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	4.47e-07	156	61	7	int:CPEB4
Interaction	SMG7 interactions	NCOA2 TRIM66 NCOA6 RBM12 RBMS1 TNRC6C R3HDM1 CREBBP PRRC2B	4.69e-07	319	61	9	int:SMG7
Interaction	TPRX2 interactions	NCOA2 NCOA6 SATB2 OGT CREBBP	7.29e-07	56	61	5	int:TPRX2
Interaction	CRX interactions	NCOA2 BCL9L KMT2C SATB2 SS18L1 ZMIZ1 CREBBP PRRC2B	9.43e-07	254	61	8	int:CRX
Interaction	PAX8 interactions	NCOA2 KMT2C SATB2 SS18L1 CREBBP PRRC2B	1.06e-06	111	61	6	int:PAX8
Interaction	PPIC interactions	UBQLN2 UBQLN1 SGTB UBQLN4	1.08e-06	26	61	4	int:PPIC
Interaction	TBXT interactions	NCOA2 KMT2C NCOA6 SATB2 SS18L1 CREBBP	1.37e-06	116	61	6	int:TBXT
Interaction	WFDC12 interactions	UBQLN2 UBQLN1 SGTB	1.46e-06	8	61	3	int:WFDC12
Interaction	FAM120C interactions	TRIM66 RBMS1 PABPC4 AIP TNRC6C R3HDM1 PRRC2B	1.74e-06	191	61	7	int:FAM120C
Interaction	CELF1 interactions	RBM12 ILF3 OGT RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	2.41e-06	288	61	8	int:CELF1
Interaction	FEV interactions	NCOA2 KMT2C NCOA6 SATB2 SS18L1 CREBBP PRRC2B	2.61e-06	203	61	7	int:FEV
Interaction	EP300 interactions	NCOA2 FOXO1 FOXO3 NCOA6 OSBP MCMBP ILF3 UBQLN1 SS18L1 PABPC4 MITF PLCG1 MAML2 MED1 CREBBP ARF5	2.78e-06	1401	61	16	int:EP300
Interaction	RBMS1 interactions	OGT UBQLN2 UBQLN1 RBMS1 PABPC4 R3HDM1 PRRC2B	2.97e-06	207	61	7	int:RBMS1
Interaction	PLAAT3 interactions	UBQLN2 UBQLN1 UBQLN4	4.28e-06	11	61	3	int:PLAAT3
Interaction	NUP35 interactions	NCOA2 BCL9L KMT2C NCOA6 RBM12 ILF3 ZMIZ1 CREBBP PRRC2B	4.89e-06	424	61	9	int:NUP35
Interaction	ITPRIPL1 interactions	UBQLN2 UBQLN1 SGTB UBQLN4	6.40e-06	40	61	4	int:ITPRIPL1
Interaction	SOD3 interactions	UBQLN2 UBQLN1 SGTB	7.39e-06	13	61	3	int:SOD3
Interaction	SOX17 interactions	NCOA2 KMT2C NCOA6 SATB2 ILF3	1.01e-05	95	61	5	int:SOX17
Interaction	CEBPA interactions	NCOA2 KMT2C NCOA6 SATB2 RBM12 ILF3 OGT UBQLN1 PABPC4 PRPF38B AIP MED1 CREBBP PRRC2B	1.59e-05	1245	61	14	int:CEBPA
Interaction	ALG13 interactions	NCOA2 TRIM66 RBM12 RBMS1 R3HDM1 PRRC2B	1.89e-05	183	61	6	int:ALG13
Interaction	PRAP1 interactions	UBQLN2 UBQLN1 SGTB	2.08e-05	18	61	3	int:PRAP1
Interaction	TNRC6A interactions	TRIM66 KMT2C NCOA6 RBMS1 TNRC6C MED1 PRRC2B	2.13e-05	280	61	7	int:TNRC6A
Interaction	SERPINE1 interactions	UBQLN2 UBQLN1 SGTB UBQLN4	2.15e-05	54	61	4	int:SERPINE1
Interaction	PRRC2A interactions	UBQLN2 UBQLN1 RBMS1 PABPC4 UBQLN4 TNRC6C R3HDM1 PRRC2B	2.16e-05	389	61	8	int:PRRC2A
Interaction	TBR1 interactions	NCOA2 BCL9L KMT2C SATB2 ZMIZ1	2.35e-05	113	61	5	int:TBR1
Interaction	SMIM2 interactions	UBQLN2 UBQLN1	2.70e-05	3	61	2	int:SMIM2
Interaction	DEFB115 interactions	UBQLN2 UBQLN1	2.70e-05	3	61	2	int:DEFB115
Interaction	SLC5A10 interactions	UBQLN1 UBQLN4	2.70e-05	3	61	2	int:SLC5A10
Interaction	KLF5 interactions	NCOA2 KMT2C NCOA6 OGT CREBBP PRRC2B	2.71e-05	195	61	6	int:KLF5
Interaction	RAI2 interactions	UBQLN1 SGTB UBQLN4	2.90e-05	20	61	3	int:RAI2
Interaction	GATA2 interactions	KMT2C NCOA6 SATB2 MED1 CREBBP PRRC2B	3.04e-05	199	61	6	int:GATA2
Interaction	FUBP3 interactions	RBM12 OGT RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	3.11e-05	297	61	7	int:FUBP3
Interaction	HSPA13 interactions	OGT UBQLN2 UBQLN1 SGTB UBQLN4	3.40e-05	122	61	5	int:HSPA13
Interaction	AR interactions	NCOA2 FOXO1 BCL9L KMT2C NCOA6 RBM12 OGT PLCG1 ZMIZ1 MED1 CREBBP PRRC2B	3.53e-05	992	61	12	int:AR
Interaction	ERP29 interactions	UBQLN2 UBQLN1 SGTB UBQLN4 PRRC2B	3.67e-05	124	61	5	int:ERP29
Interaction	PPARG interactions	NCOA2 FOXO1 KMT2C NCOA6 ILF3 MED1 CREBBP	3.83e-05	307	61	7	int:PPARG
Interaction	SMR3B interactions	FOXO1 UBQLN2 UBQLN1	3.90e-05	22	61	3	int:SMR3B
Interaction	VDR interactions	NCOA2 FOXO3 NCOA6 MED1 CREBBP	4.12e-05	127	61	5	int:VDR
Interaction	FOS interactions	NCOA2 KMT2C NCOA6 SS18L1 MITF NFAT5 CREBBP	4.25e-05	312	61	7	int:FOS
Interaction	YTHDF2 interactions	OGT RBMS1 PABPC4 TNRC6C R3HDM1 CREBBP PRRC2B	4.25e-05	312	61	7	int:YTHDF2
Interaction	PABPC1 interactions	FOXO1 KMT2C ILF3 OGT UBQLN2 RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	4.31e-05	699	61	10	int:PABPC1
Interaction	DEFA6 interactions	UBQLN2 UBQLN1 SGTB	4.48e-05	23	61	3	int:DEFA6
Interaction	PAX9 interactions	NCOA2 BCL9L KMT2C NCOA6 SATB2	4.60e-05	130	61	5	int:PAX9
Interaction	MYDGF interactions	UBQLN2 UBQLN1 SGTB UBQLN4	4.76e-05	66	61	4	int:MYDGF
Interaction	UCHL5 interactions	OSBP OGT UBQLN2 UBQLN1 PSME4 UBQLN4 PLCG1	4.89e-05	319	61	7	int:UCHL5
Interaction	NR1H2 interactions	NCOA2 FOXO3 NCOA6 MED1	5.35e-05	68	61	4	int:NR1H2
Interaction	RARA interactions	NCOA2 FOXO1 NCOA6 UBQLN1 MED1 CREBBP	5.74e-05	223	61	6	int:RARA
Interaction	SMAD3 interactions	FOXO1 FOXO3 NCOA6 SS18L1 UBQLN4 ZMIZ1 SIK3 CREBBP	5.79e-05	447	61	8	int:SMAD3
Interaction	DMKN interactions	UBQLN2 UBQLN1 SGTB	5.79e-05	25	61	3	int:DMKN
Interaction	ETNK1 interactions	UBQLN2 UBQLN1 SGTB	5.79e-05	25	61	3	int:ETNK1
Interaction	RAD23A interactions	OGT UBQLN2 UBQLN1 PSME4 UBQLN4 CREBBP	5.88e-05	224	61	6	int:RAD23A
Interaction	FOXP2 interactions	BNC2 SATB2 ELMO3 NFAT5	6.00e-05	70	61	4	int:FOXP2
Interaction	SCG5 interactions	UBQLN2 UBQLN1 UBQLN4	6.53e-05	26	61	3	int:SCG5
Interaction	IGLC1 interactions	FOXO1 UBQLN1 UBQLN4	6.53e-05	26	61	3	int:IGLC1
Interaction	ZG16B interactions	FOXO1 UBQLN2 UBQLN1 SGTB UBQLN4	7.01e-05	142	61	5	int:ZG16B
Interaction	FUCA1 interactions	OGT UBQLN2 RBMS1	7.33e-05	27	61	3	int:FUCA1
Interaction	CREBBP interactions	NCOA2 FOXO1 FOXO3 NCOA6 OGT SS18L1 MITF MAML2 CREBBP	7.45e-05	599	61	9	int:CREBBP
Interaction	NCOA6 interactions	NCOA2 KMT2C NCOA6 MED1 CREBBP	7.74e-05	145	61	5	int:NCOA6
Interaction	DAZL interactions	ILF3 RBMS1 PABPC4 R3HDM1 PRRC2B	7.74e-05	145	61	5	int:DAZL
Interaction	RSRC2 interactions	OGT UBQLN2 UBQLN1 UBQLN4	7.86e-05	75	61	4	int:RSRC2
Interaction	CPEB1 interactions	RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	8.00e-05	146	61	5	int:CPEB1
Interaction	ELF5 interactions	KMT2C SATB2 ILF3 SS18L1 UBQLN4	8.26e-05	147	61	5	int:ELF5
Interaction	FZD7 interactions	UBQLN2 UBQLN1 SGTB UBQLN4	8.71e-05	77	61	4	int:FZD7
Interaction	GUCA2B interactions	UBQLN2 UBQLN1	8.96e-05	5	61	2	int:GUCA2B
Interaction	PSORS1C2 interactions	UBQLN2 UBQLN1 SGTB	9.12e-05	29	61	3	int:PSORS1C2
Interaction	COL1A2 interactions	FOXO1 UBQLN2 UBQLN1 SGTB	9.16e-05	78	61	4	int:COL1A2
Interaction	HERC5 interactions	HSPG2 ILF3 UBQLN1 PLCG1 MED1 CREBBP	9.64e-05	245	61	6	int:HERC5
Interaction	YWHAH interactions	NCOA2 FOXO1 FOXO3 NCOA6 MCMBP ILF3 OGT MITF SIK3 MED1 R3HDM1 CREBBP	9.73e-05	1102	61	12	int:YWHAH
Interaction	YTHDF3 interactions	FOXO1 RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	9.86e-05	246	61	6	int:YTHDF3
Interaction	IGF2BP2 interactions	ILF3 OGT RBMS1 PABPC4 KTI12 R3HDM1 PRRC2B	9.90e-05	357	61	7	int:IGF2BP2
Interaction	ERP27 interactions	UBQLN2 UBQLN1 UBQLN4	1.01e-04	30	61	3	int:ERP27
Interaction	PPARGC1A interactions	FOXO1 NCOA6 MED1 CREBBP	1.11e-04	82	61	4	int:PPARGC1A
Interaction	SOX7 interactions	NCOA2 KMT2C SATB2 CREBBP	1.11e-04	82	61	4	int:SOX7
Interaction	PAX6 interactions	KMT2C NCOA6 SATB2 SS18L1 MITF CREBBP PRRC2B	1.16e-04	366	61	7	int:PAX6
Interaction	HELZ interactions	RBMS1 PABPC4 TNRC6C R3HDM1 CREBBP PRRC2B	1.25e-04	257	61	6	int:HELZ
Interaction	LSM14A interactions	ILF3 OGT UBQLN2 RBMS1 R3HDM1 PRRC2B	1.33e-04	260	61	6	int:LSM14A
Interaction	BCL2L11 interactions	FOXO1 FOXO3 UBQLN2 FEM1C	1.34e-04	86	61	4	int:BCL2L11
Interaction	FOXO3B interactions	FOXO1 FOXO3	1.34e-04	6	61	2	int:FOXO3B
Interaction	C1QTNF4 interactions	UBQLN2 UBQLN1	1.34e-04	6	61	2	int:C1QTNF4
Interaction	GSC interactions	BCL9L KMT2C SATB2 CREBBP	1.40e-04	87	61	4	int:GSC
Interaction	IGF2BP1 interactions	ILF3 OGT UBQLN2 UBQLN1 RBMS1 PABPC4 R3HDM1 PRRC2B	1.41e-04	508	61	8	int:IGF2BP1
Interaction	LHX4 interactions	NCOA2 BCL9L KMT2C SATB2 UBQLN1	1.46e-04	166	61	5	int:LHX4
Interaction	BMI1 interactions	ILF3 OGT ENOX1 SS18L1 PABPC4 UTP20 PLCG1 CREBBP PRRC2B	1.54e-04	659	61	9	int:BMI1
Interaction	MKRN2 interactions	SATB2 UBQLN2 RBMS1 PABPC4 TNRC6C R3HDM1 PRRC2B	1.58e-04	385	61	7	int:MKRN2
Interaction	RXRA interactions	NCOA2 NCOA6 UBQLN4 MED1 CREBBP	1.59e-04	169	61	5	int:RXRA
Interaction	KTI12 interactions	RAB3GAP1 KTI12 TNRC6C	1.61e-04	35	61	3	int:KTI12
Interaction	FOXO4 interactions	FOXO1 OGT CREBBP	1.61e-04	35	61	3	int:FOXO4
Interaction	MIEF2 interactions	UBQLN2 UBQLN1 UBQLN4	1.61e-04	35	61	3	int:MIEF2
Interaction	PPARA interactions	NCOA2 NCOA6 AIP MED1	1.74e-04	92	61	4	int:PPARA
Interaction	NUP58 interactions	ILF3 UBQLN2 UBQLN1 TNRC6C	1.74e-04	92	61	4	int:NUP58
Cytoband	2q21.3	RAB3GAP1 R3HDM1	1.80e-04	15	61	2	2q21.3
GeneFamily	Ubiquilin family	UBQLN2 UBQLN1 UBQLN4	1.08e-07	5	41	3	783
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 KAT6B CREBBP	7.20e-06	17	41	3	486
GeneFamily	PHD finger proteins	TRIM66 KMT2C KAT6B	1.11e-03	90	41	3	88
GeneFamily	RNA binding motif containing	RBM12 ENOX1 RBMS1 PABPC4	1.35e-03	213	41	4	725
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2C SMYD1	2.69e-03	34	41	2	487
GeneFamily	Forkhead boxes	FOXO1 FOXO3	4.27e-03	43	41	2	508
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 FOXO3 RAB3GAP1 SATB2 ATP2C1 OGT PSME4 RBMS1 MITF UTP20 ZMIZ1 SIK3 MED1 R3HDM1 KAT6B CREBBP	7.48e-11	856	61	16	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	FOXO1 KMT2C MCMBP RBM12 OGT RBMS1 PRPF38B PLCG1 AIP TNRC6C SIK3 MED1 KAT6B NFAT5 CREBBP PRRC2B	1.99e-07	1492	61	16	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	FOXO3 RAB3GAP1 SATB2 OGT RBMS1 ZMIZ1 R3HDM1 KAT6B CREBBP	1.26e-06	466	61	9	M13522
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	OSBP ATP2C1 OGT R3HDM1 KAT6B CREBBP	1.78e-06	157	61	6	M7733
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	OGT PRPF38B TNRC6C R3HDM1 NFAT5 DISP1	2.45e-06	166	61	6	M6826
Coexpression	GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	RAB3GAP1 OGT MITF R3HDM1 KAT6B DISP1	3.79e-06	179	61	6	M6689
Coexpression	LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B	NCOA2 FOXO1 KMT2C MITF SIK3	4.24e-06	103	61	5	M39240
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	KMT2C OGT UBQLN1 PLCG1 TNRC6C PRRC2B	6.97e-06	199	61	6	M9443
Coexpression	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	NCOA6 OSBP ILF3 OGT MITF MED1	6.97e-06	199	61	6	M6839
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	NCOA2 FOXO1 FOXO3 SS18L1 MAML2 KAT6B CREBBP	9.97e-06	323	61	7	M9150
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	KMT2C MITF MAML2 SIK3 NFAT5	4.93e-05	171	61	5	M39234
Coexpression	BENPORATH_NANOG_TARGETS	FOXO1 FOXO3 CACNA1A BCL9L ILF3 UBQLN4 R3HDM1 FEM1C NFAT5 FEM1A	8.70e-05	988	61	10	M6616
Coexpression	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	BCL9L RAB3GAP1 SGTB UTP20 MAML2	8.75e-05	193	61	5	M7464
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	FOXO3 NCOA6 PLCG1 SIK3 KAT6B	9.41e-05	196	61	5	M5381
Coexpression	GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	FOXO1 FOXO3 RBM12 OGT MITF	1.03e-04	200	61	5	M7640
Coexpression	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP	FOXO1 FOXO3 BNC2 PABPC4 ZMIZ1	1.03e-04	200	61	5	M3407
Coexpression	GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP	FOXO1 NCOA6 OSBP TNRC6C ZMIZ1	1.03e-04	200	61	5	M8567
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	FOXO3 NCOA6 OSBP ZMIZ1 SIK3 FEM1C NFAT5 CREBBP PRRC2B	1.13e-04	822	61	9	M6782
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 FOXO1 FOXO3 KMT2C MAML2 SIK3 NFAT5	8.60e-09	193	61	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	FOXO1 BNC2 NAALADL1 UBQLN4 PLCG1	2.32e-06	155	61	5	a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	BCL9L NCOA6 SATB2 DISP1 ADH1A	2.62e-06	159	61	5	b4bc888e978b1b577721b891b0af6ba9a1607044
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	NCOA2 RAB3GAP1 MED1 NFAT5 CREBBP	5.64e-06	186	61	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NCOA2 SATB2 MAML2 SIK3 NFAT5	6.10e-06	189	61	5	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCOA2 FOXO3 CACNA1A MITF	8.10e-05	167	61	4	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCMBP ILF3 PLCG1 MED1	8.88e-05	171	61	4	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	facs\|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCMBP SLC25A39 PLCG1 MED1	9.08e-05	172	61	4	a2d0a64ebf09d219a07d6bbad1056bad6d46b9be
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL9L HSPG2 UTP20 ADH1A	9.29e-05	173	61	4	a5172dee859bf6c2eed46c48bd64dfef0ff9f28f
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL9L HSPG2 UTP20 ADH1A	9.29e-05	173	61	4	639b5b0b33ce5aa0bc26363c059717012ddc14c0
ToppCell	hematopoetic_progenitors-CD34+_MEP_2\|World / Lineage and Cell class	HSPG2 NAALADL1 ATP2C1 MGAM2	1.13e-04	182	61	4	a7e7aa10f14111a6c7ba22e0f1668dcaa124714d
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FOXO1 BNC2 UBQLN4 PLCG1	1.15e-04	183	61	4	807d64deaf4e50dccf6f831f88578a6d903c1421
ToppCell	Control-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	ATP2C1 PSME4 MITF DISP1	1.20e-04	185	61	4	85cb81759589a26d83676cffbf2bc37399683c10
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BNC2 NAALADL1 UBQLN4 PLCG1	1.23e-04	186	61	4	76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	KMT2C ATP2C1 SIK3 NFAT5	1.28e-04	188	61	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Endothelial-Endothelial-E\|Endothelial / shred on cell class and cell subclass (v4)	SLC6A2 FOXO1 CACNA1A HSPG2	1.28e-04	188	61	4	2777eb7689b271c199021fe7d9db88ccebff14de
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	BCL9L OGT PLCG1 MAML2	1.31e-04	189	61	4	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FOXO1 FOXO3 BNC2 MAML2	1.36e-04	191	61	4	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	OGT SGTB MAML2 TNRC6C	1.36e-04	191	61	4	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	SGTB RBMS1 PLCG1 AIP	1.39e-04	192	61	4	1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	KMT2C OGT MAML2 SIK3	1.39e-04	192	61	4	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	FOXO1 BNC2 MAML2 SIK3	1.39e-04	192	61	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	OGT PSME4 PRPF38B PLCG1	1.41e-04	193	61	4	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SATB2 MAML2 NFAT5 DISP1	1.41e-04	193	61	4	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	FOXO1 FOXO3 BNC2 MAML2	1.44e-04	194	61	4	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	IPF-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	FOXO1 OGT RBMS1 MAML2	1.50e-04	196	61	4	6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	FOXO1 OGT RBMS1 MAML2	1.50e-04	196	61	4	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNC2 ENOX1 MITF ZMIZ1	1.50e-04	196	61	4	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BNC2 OGT PLCG1 TNRC6C	1.53e-04	197	61	4	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	FOXO1 HSPG2 BNC2 SIK3	1.56e-04	198	61	4	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	human_hepatoblastoma-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ATP2C1 UBQLN1 PSME4 FEM1C	1.59e-04	199	61	4	e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 KMT2C MAML2 SIK3	1.59e-04	199	61	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
Computational	Neighborhood of MYST2	FOXO3 ILF3 SS18L1 ZMIZ1 KAT6B PRRC2B	6.56e-05	172	44	6	GCM_MYST2
Computational	Neighborhood of SUFU	FOXO3 UBQLN2 SS18L1 KAT6B	2.66e-04	77	44	4	GCM_SUFU
Computational	Neighborhood of UBE2N	FOXO3 SS18L1 ZMIZ1 KAT6B PRRC2B	3.91e-04	154	44	5	GCM_UBE2N
Drug	glutamin	FOXO1 FOXO3 CACNA1A UBQLN2 UBQLN1 PSME4 UBQLN4 KAT6B NFAT5 CREBBP	3.20e-07	461	60	10	CID000000738
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 BNC2 PSME4 RBMS1 ZMIZ1 KAT6B	5.88e-06	171	60	6	7535_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 BNC2 NCOA6 KAT6B CREBBP PRRC2B	7.40e-06	178	60	6	7245_DN
Drug	testosterone-3-carboxymethyloxime-bovine serum albumin conjugate	NCOA2 FOXO1 HSPG2 NCOA6 ZMIZ1 MED1	9.23e-06	185	60	6	ctd:C045037
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TRIM66 PSME4 MITF MED1 KAT6B NFAT5	9.23e-06	185	60	6	1673_DN
Drug	cytochalasin B; Down 200; 20.8uM; MCF7; HT_HG-U133A_EA	NCOA2 ATP2C1 RBM12 PSME4 SS18L1 FEM1C	9.81e-06	187	60	6	1122_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	NCOA2 HSPG2 RBM12 ILF3 PSME4 MED1	1.25e-05	195	60	6	6918_UP
Drug	Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A	NCOA2 FOXO1 RAB3GAP1 SATB2 OGT PLCG1	1.28e-05	196	60	6	1809_UP
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	NCOA2 ATP2C1 OGT UTP20 MED1 NFAT5	1.32e-05	197	60	6	4476_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A	TRIM66 OSBP ATP2C1 MED1 KAT6B PRRC2B	1.36e-05	198	60	6	6228_DN
Drug	Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	FOXO1 HSPG2 BNC2 ELMO3 PLCG1 KAT6B	1.40e-05	199	60	6	2147_DN
Drug	cloquintocet-mexyl	MGAM OGT	2.05e-05	3	60	2	CID000093528
Drug	Uranium pentafluoride	HSPG2 NCOA6	2.05e-05	3	60	2	CID003014661
Drug	1,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3	NCOA2 MED1	4.08e-05	4	60	2	ctd:C408047
Drug	AC1OCF9M	HSPG2 MGAM ADH1A	6.05e-05	29	60	3	CID006918304
Drug	MF101 extract	NCOA2 CREBBP	6.79e-05	5	60	2	ctd:C517398
Drug	methyl-2-hydroxypropylnitrosamine	CACNA1A SMYD1	6.79e-05	5	60	2	CID000107719
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA6 ZMIZ1 KAT6B CREBBP	8.57e-05	170	60	5	1050_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA6 ZMIZ1 KAT6B CREBBP	9.06e-05	172	60	5	1072_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 NCOA6 ZMIZ1 KAT6B CREBBP	9.57e-05	174	60	5	1659_DN
Drug	8-hydroxy-5,7-dimethoxy-3-methyl-2-tridec-12-enyl-chromone	MGAM NCOA6 ILF3	9.82e-05	34	60	3	CID016122551
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA6 ILF3 KAT6B CREBBP	9.83e-05	175	60	5	1058_DN
Drug	butamben	NCOA2 MED1	1.02e-04	6	60	2	ctd:C004605
Drug	26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3	NCOA2 MED1	1.02e-04	6	60	2	ctd:C040488
Drug	N-nitrosomethyl(2-oxopropyl)amine	CACNA1A SMYD1	1.02e-04	6	60	2	CID000104910
Drug	DMNM	CACNA1A SMYD1	1.02e-04	6	60	2	CID000015081
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 NCOA6 ZMIZ1 KAT6B CREBBP	1.04e-04	177	60	5	1645_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	ILF3 PSME4 MED1 KAT6B NFAT5	1.06e-04	178	60	5	3998_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 UTP20 ZMIZ1 KAT6B PRRC2B	1.12e-04	180	60	5	5511_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 OGT ZMIZ1 KAT6B CREBBP	1.15e-04	181	60	5	6951_DN
Drug	3-7a	CACNA1A MGAM KERA	1.17e-04	36	60	3	CID011987860
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ILF3 UTP20 MED1 KAT6B NFAT5	1.34e-04	187	60	5	4302_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SATB2 PSME4 UTP20 KAT6B NFAT5	1.38e-04	188	60	5	4845_DN
Drug	Fp 3	MGAM NCOA6	1.42e-04	7	60	2	CID000203335
Drug	formylglutamate	MGAM UROC1	1.42e-04	7	60	2	CID000102672
Drug	n-hexyl-6-	MGAM NCOA6	1.42e-04	7	60	2	CID003032893
Drug	N-nitrosobis(2-acetoxypropyl)amine	CACNA1A SMYD1	1.42e-04	7	60	2	CID000091675
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	NCOA2 FOXO1 PSME4 MED1 NFAT5	1.48e-04	191	60	5	4279_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ILF3 MITF AIP KAT6B NFAT5	1.48e-04	191	60	5	4811_DN
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	RAB3GAP1 MCMBP MITF PLCG1 NFAT5	1.59e-04	194	60	5	7098_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	NCOA2 HSPG2 ATP2C1 PSME4 NFAT5	1.63e-04	195	60	5	4398_DN
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A	NCOA2 ILF3 MED1 KAT6B NFAT5	1.67e-04	196	60	5	4844_DN
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	SATB2 ILF3 PSME4 FEM1C NFAT5	1.67e-04	196	60	5	2108_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; HL60; HG-U133A	OSBP ILF3 OGT AIP KAT6B	1.67e-04	196	60	5	1996_DN
Drug	Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A	NCOA2 RBM12 PSME4 MITF NFAT5	1.71e-04	197	60	5	2812_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 OSBP ILF3 PLCG1 FEM1C	1.71e-04	197	60	5	1055_UP
Drug	Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A	FOXO1 RBM12 KAT6B NFAT5 PRRC2B	1.75e-04	198	60	5	6208_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A	FOXO1 SATB2 MITF KAT6B CREBBP	1.79e-04	199	60	5	7422_DN
Disease	amyotrophic lateral sclerosis type 15 (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	7.59e-09	3	59	3	DOID:0060206 (implicated_via_orthology)
Disease	frontotemporal dementia (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	1.65e-06	12	59	3	DOID:9255 (implicated_via_orthology)
Disease	Sezary Syndrome	KMT2C PLCG1 CREBBP	2.15e-05	27	59	3	C0036920
Disease	1,5 anhydroglucitol measurement	MGAM RAB3GAP1 MGAM2	2.67e-05	29	59	3	EFO_0008009
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	2.97e-05	30	59	3	DOID:332 (implicated_via_orthology)
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	SS18L1 UBQLN4 CREBBP	1.39e-04	50	59	3	C1862939
Disease	neurodegenerative disease (implicated_via_orthology)	UBQLN2 UBQLN1 SLC25A39 UBQLN4	2.06e-04	145	59	4	DOID:1289 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	NCOA2 FOXO1 FOXO3 KMT2C	2.73e-04	156	59	4	DOID:10283 (is_marker_for)
Disease	body surface area	FOXO1 FOXO3 TRIM66 BNC2 SATB2 KERA ZMIZ1	2.89e-04	643	59	7	EFO_0022196
Disease	neutrophil count	FOXO1 CACNA1A BNC2 RBMS1 UBQLN4 MITF ZMIZ1 SIK3 R3HDM1 CREBBP	3.80e-04	1382	59	10	EFO_0004833
Disease	urate measurement	BNC2 NCOA6 NAALADL1 UBQLN4 AIP ZMIZ1 NFAT5 PRRC2B	3.92e-04	895	59	8	EFO_0004531
Disease	Tremor, Rubral	CACNA1A UROC1	4.63e-04	16	59	2	C0750940
Disease	Ataxia, Appendicular	CACNA1A UROC1	4.63e-04	16	59	2	C0750937
Disease	Ataxia, Motor	CACNA1A UROC1	4.63e-04	16	59	2	C0278161
Disease	Abnormal coordination	CACNA1A UROC1	4.63e-04	16	59	2	C0520966
Disease	Ataxia, Truncal	CACNA1A UROC1	4.63e-04	16	59	2	C0427190
Disease	Ataxia, Sensory	CACNA1A UROC1	4.63e-04	16	59	2	C0240991
Disease	thalamus volume	FOXO3 SGTB NFAT5	6.68e-04	85	59	3	EFO_0006935
Disease	metabolic syndrome	NAALADL1 PABPC4 SIK3 NFAT5	6.97e-04	200	59	4	EFO_0000195
Disease	FEV/FEC ratio	FOXO1 FOXO3 HSPG2 MGAM BNC2 ENOX1 RBMS1 PABPC4 MAML2	7.01e-04	1228	59	9	EFO_0004713
Disease	vital capacity	FOXO3 TRIM66 HSPG2 BNC2 NCOA6 RBMS1 ZMIZ1 MED1 NFAT5	7.34e-04	1236	59	9	EFO_0004312
Disease	interleukin-2 receptor subunit alpha measurement	SLC6A2 PRPF38B	8.05e-04	21	59	2	EFO_0010587
Disease	progranulin measurement	NCOA2 UBQLN1	8.85e-04	22	59	2	EFO_0004625
Disease	forced expiratory volume	BNC2 NCOA6 ILF3 RBMS1 MED1 NFAT5 PRRC2B	9.70e-04	789	59	7	EFO_0004314
Disease	brain stem volume measurement	FOXO3 SGTB	1.05e-03	24	59	2	EFO_0010605
Disease	Adenoid Cystic Carcinoma	FOXO3 KMT2C CREBBP	1.07e-03	100	59	3	C0010606
Disease	Ataxia	CACNA1A UROC1	1.14e-03	25	59	2	C0004134
Disease	apolipoprotein A 1 measurement	NCOA2 MGAM PABPC4 AIP ZMIZ1 SIK3 R3HDM1	1.47e-03	848	59	7	EFO_0004614
Disease	JT interval	NCOA2 MITF ZMIZ1 CREBBP	1.54e-03	248	59	4	EFO_0007885
Disease	waist circumference	FOXO3 TRIM66 ATP2C1 ZMIZ1 NFAT5	1.67e-03	429	59	5	EFO_0004342

Protein segments in the cluster

Peptide	Gene	Start	Entry
MLAIPAMATNPQNAA	CACNA1A	1106	O00555
ANPNPRLHMPMLRNN	BNC2	491	Q6ZN30
PPDSQNLSMNPMLLL	ADH1A	296	P07327
LLVFANKQDMPNAMP	ARF5	121	P84085
PGMHQQPSLQNLNAM	CREBBP	2131	Q92793
ENLGSEQMMPPAQAA	CCDC157	96	Q569K6
FLPLDNQRMPQMLPQ	DISP1	66	Q96F81
TLMNFPNPLNAMQIL	ATP2C1	721	P98194
LQQNPQPLIFHMEML	AIP	141	O00170
VMMQLSVPNNPQSCA	R3HDM1	831	Q15032
MNLNNNLNPMFLGPL	RBM12	266	Q9NTZ6
MQDLLGMNNDFPPRA	RAB3GAP1	101	Q15042
LENNMLMLPSVRPQD	HSPG2	3621	P98160
LQPASMISPLAQQMS	RBMS1	331	P29558
NMSVNLMPAPAYNVN	KAT6B	1966	Q8WYB5
LMPAPAYNVNSVNMN	KAT6B	1971	Q8WYB5
DMQQSNLDPLSPMTA	FEM1C	366	Q96JP0
ASMLAAAPPQEQKQM	PABPC4	556	Q13310
DMPRPLNNSQMNNPV	KMT2C	2521	Q8NEZ4
MHPNNENLPQLANMF	KTI12	331	Q96EK9
LMNSNAMEVTLQPAP	MGAM2	276	Q2M2H8
LMNSNAMEVVLQPAP	MGAM	321	O43451
QDMQQSPLYSPQNNM	NFAT5	1391	O94916
MPVNFNEPLSMLQRL	OSBP	436	P22059
PKQLLANQNNPMMPR	MAML2	896	Q8IZL2
NPMILSRAQLMPQGQ	NCOA6	646	Q14686
MSPLPQMPIQTLQDN	FOXO1	431	Q12778
ALDMQQSNLEPLSPM	FEM1A	416	Q9BSK4
KAEPPQAMNALMRLN	ILF3	396	Q12906
KAQPPNLHLMNLQNM	BCL9L	1351	Q86UU0
NLQNMMAEQTPSRPP	BCL9L	1361	Q86UU0
VNMNLMDASVPPLAL	ELMO3	176	Q96BJ8
ASAAQPIPENMDNSM	KIAA1210	631	Q9ULL0
LCQPLMNPKVQQNMF	KIAA1210	986	Q9ULL0
TQLPQELPQMMAAAA	ENOX1	11	Q8TC92
NHPMLMNLLKDNPAQ	MED1	641	Q15648
QLIPPNMEEYMNSLL	MCMBP	526	Q9BTE3
DSSNTALNMPVIPMN	OGT	766	O15294
LRNDPMMSFAAQPNQ	FOXO3	511	O43524
MLLARMNPQVQPENN	SLC6A2	1	P23975
MQSLPQEVMEANLPS	UTP20	1831	O75691
NTNPMNSSPNPINAM	TNRC6C	186	Q9HCJ0
PLAGLNPNMNVNSMD	TNRC6C	1266	Q9HCJ0
QLNMAKNALRNMPPR	KERA	196	O60938
LNNQPMQVMAEPSNE	SMYD1	466	Q8NB12
RPMHLPNMNQLASLG	SATB2	251	Q9UPW6
QVAPNVNFMHNLLPM	SIK3	501	Q9Y2K2
VNFMHNLLPMQNLQP	SIK3	506	Q9Y2K2
MQSLLPAPPTQNMNL	SS18L1	71	O75177
NLFPNQLPGMDMIKQ	NCOA2	1441	Q15596
MAMALELQAQASPQP	ZSCAN20	1	P17040
SAPNSPMAMLTLNSN	MITF	176	O75030
MADQDPAGISPLQQM	SLC25A39	1	Q9BZJ4
MIMNNLDPAVAQFPQ	UROC1	106	Q96N76
MNLNPMILTNILSSP	PRPF38B	56	Q5VTL8
ENPFVQSMLSNPDLM	UBQLN1	191	Q9UMX0
SLSQNPDLAAQMMLN	UBQLN1	406	Q9UMX0
PDLAAQMMLNNPLFA	UBQLN1	411	Q9UMX0
VALNFQTPDKPMQMN	PLCG1	1036	P19174
SQMLDSQLPQLTMPL	PRRC2B	2066	Q5JSZ5
MPQLLMNLSAHLNDP	PSME4	1781	Q14997
NPAFISMAASLMQNP	SGTB	221	Q96EQ0
MENPFVQSMLSNPDL	UBQLN2	186	Q9UHD9
SNPDLMRQLIMANPQ	UBQLN2	196	Q9UHD9
QNPDLAAQMMLNSPL	UBQLN2	401	Q9UHD9
AAQMMLNSPLFTANP	UBQLN2	406	Q9UHD9
QMQNPDTLSAMSNPR	UBQLN2	436	Q9UHD9
FQSMPNLISDSPQAM	TRIM66	711	O15016
ANPQMQQLMERNPEI	UBQLN4	221	Q9NRR5
VLGNPMANANNPMNP	ZMIZ1	181	Q9ULJ6
PMRSMNESQNPLLAN	ZDHHC15	296	Q96MV8
SPDPLQVRMLNDQLM	NAALADL1	646	Q9UQQ1